Mednet Logo
HomeGynecologic OncologyQuestion

Do the results of the ConCerv and SHAPE trials alter how you might counsel a patient incidentally found to have ≤IB1 after simple hysterectomy?

3 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · Vanderbilt University School of Medicine

The ConCerv and SHAPE trials have demonstrated that selected patients with low-risk, less than or equal to stage IB1 cervical cancers can be safely treated with simple, extrafascial hysterectomy with lymph node assessment. Given those findings, if a patient met the criteria for inclusion in the ConC...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Gynecologic Oncology · University of California Irvine Medical Center

No, for IB1 or less following hysterectomy I would not offer a parametrectomy or upper vaginectomy. If the stage was IB1 or IA2 I would make sure the patient's nodes had been evaluated pathologically.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Gynecologic Oncology · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

No, I would not discuss a parametrectomy or upper vaginectomy for these patients if the stage is <= IB1, however, I would consider taking them back for evaluation of the lymph nodes if they were not evaluated, or serial imaging with PET scans.

Register or Sign In to see full answer

Do the results of the ConCerv and SHAPE trials alter how you might counsel a patient incidentally found to have ≤IB1 after simple hysterectomy? | Mednet